Articles with the keyword: 
Induced stem cell lines may soon be available from Harvard
Darkfrog submitted, created time 3 months 2 weeks (sciencenow.sciencemag.org)
A few weeks ago, we talked about how researchers had been able to take a cell from an ALS patient and develop a working, research-quality pluripotent cell line. Well the next step has been taken.
I've been saying that induced pluripotent stem cells might become the preferred research model (over embryonic stem cells), but only if they became easier to obtain than embryonic stem cells. It looks as though that might happen soon. The Harvard Stem Cell Institute is dedicating an iPS core lab 
Small Win for Wisconsin in Stem Cell Fight
Sue Wu submitted, created time 8 months 3 weeks (sciencenow.sciencemag.org)
With a government decision upholding an important 2006 patent on human stem cell techniques, biomedical researcher James Thomson and his school, the University of Wisconsin, Madison, have won the latest skirmish in a long-running conflict over patents.
Reviewer leaked Avandia study to drug firm
jane2007 submitted, created time 9 months 3 weeks (www.nature.com)
A peer reviewer for The New England Journal of Medicine (NEJM ) broke confidentiality and leaked a damaging report about the blockbuster diabetes drug Avandia to the drug's manufacturer weeks ahead of publication. The drug would increase the risk of heart attack.
Fake(?) drugs circulate in free trade zones
Darkfrog submitted, created time 11 months 4 days (www.nytimes.com)
This is an article about the economic policies that encourage the international trade in "fake drugs." I'm halfway through the thing and it still hasn't said whether "fake" means sugar pills relabeled as antiretroviral AIDS medicine or just bona-fide generic drugs masquerading as brand name. That little tidbit ought to be in the first paragraph.
While patent violation is a crime and the companies that spent years of time and money developing drugs do deserve their fair share of the profits, this would make a big difference in how serious of an issue it is
After Stem-Cell Breakthrough, the Work Begins
jane2007 submitted, created time 11 months 3 weeks (www.nytimes.com)
After stem-cell breakthrough, the researchers have many works to perform. If stem cell researchers were oil prospectors, it could be said that they struck a gusher last week. But to realize the potential boundless riches they now must figure out how to build refineries, pipelines and gas stations.
The article tell us what we will do after the breakthrough of stem cell and the value of the technology.
Indonesia says no to bird flu virus sharing
Eric wu submitted, created time 11 months 3 weeks (www.reuters.com)
Indonesia will not share bird flu virus samples unless there is a guarantee developing nations will have control over their use and have access to cheap vaccines, a health ministry spokeswoman said on Monday.
The Gold in Yellowstone's Microbes
whitesnow submitted, created time 11 months 4 weeks (www.time.com)
Yellowstone Park's bizarre steam vents and odiferous boiling pools are more than just tourist attractions and geological curiosities. They are home to unique microbes — living organisms that thrive in extreme heat. More than that, they are valuable resources for industries searching for fresh and big profits.
\ 1
\ 
abuse@discover8.com
angelfish
kavin
DanyC
addict
siRNA Vector : pRNA-H1.1/Neo
www.genscript.com
Gly-Arg-Gly-Asp-Asn-Pro
G-R-G-D-N-P is a superior inhibitor of cell attachment to fi ...
www.genscript.com
LApro Taq DNA Polymerase
Description:
www.genscript.com
Western Membrane Forceps
The Western Membrane Forceps are crafted from No. 304 stainl ...
www.genscript.com